This session will present unpublished outcomes of 2 recently completed clinical trials with EPA and/or DHA supplementation conducted by the teams of the session speakers:
Audience will learn:
How the presented novel findings on EPA and/or DHA can be translated to Canadians to help reduce the risk for type 2 diabetes and improve the response of women with breast cancer to chemotherapy
Pr Plourde is a full professor at the Université de Sherbrooke, Canada. The goal of her research program is to prevent cognitive decline through a better understanding of the interactions between genetics and diet in the aging process and in the metabolism of omega-3 fatty acids. Her research program is developed around two research themes: (1) to understand how OM3 are transferred from the blood to the brain, (2) Maximise OM3 transport to the brain. In 2016, she received the first institutional Research Chair on lipid metabolism during aging donated by the Medical Research Center of Université de Sherbrooke. Her expertise in fatty acid analysis was recognized by joining as a co-chair the international group expert on Fatty Acid Best Practice Analysis sponsored by the International Life Science Institute-North America. In 2020, she was awarded the Canadian Nutrition Society Young Investigator Award for Outstanding Research.